
Nanox is trying to turn Zebra Medical Vision’s scan-reading software into a hospital business, not just an AI demo. The company said it had accelerated work around Nanox.AI, added Cedars-Sinai as a clinical-trial partner for an aortic valve calcification tool and pushed U.S. deployment of Nanox.ARC systems, with Chief Executive Erez Meltzer calling the fourth quarter “strong momentum.”
Today’s highest-ranked model selections.
The catalysts most likely to move markets.
A surprise around the 0.10 forecast could shift the morning growth narrative and influence Treasury yields and the dollar before the opening bell.
The day’s largest scheduled equity report can move PDD and the broader China-internet / e-commerce complex through revenue growth, margins and Temu commentary.
Deliveries, margin progression and spending on AI-enabled mobility can affect U.S.-traded Chinese EV names and related technology suppliers.